{"id":456183,"date":"2021-03-11T12:02:06","date_gmt":"2021-03-11T17:02:06","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456183"},"modified":"2021-03-11T12:02:06","modified_gmt":"2021-03-11T17:02:06","slug":"manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/","title":{"rendered":"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems<\/b><\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nManhattan Scientifics Inc. (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.otcmarkets.com%2Fstock%2FMHTX%2Foverview&amp;esheet=52394777&amp;newsitemid=20210311005814&amp;lan=en-US&amp;anchor=OTCQB%3A+MHTX&amp;index=1&amp;md5=03fe045609625e45ef006b587d3235fc\">OTCQB: MHTX<\/a>) invested $30 million and a 10-year effort to commercialize the Imagion Biosystems (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww2.asx.com.au%2Fmarkets%2Fcompany%2FIBX&amp;esheet=52394777&amp;newsitemid=20210311005814&amp;lan=en-US&amp;anchor=IBX%3A+AX&amp;index=2&amp;md5=939a4fcfb6751072181fe468c274bcdd\">IBX: AX<\/a>) super early, non- invasive, non-radioactive Cancer diagnostic, now \u201cpartnered\u201d with MD Anderson Cancer Center, Houston. The company is awaiting regulatory approval to initiate human cancer trials.\n<\/p>\n<p>\nView the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mhtx.com%2Fassets%2Fmedia%2Fpdf%2Fmhtx-chart.png&amp;esheet=52394777&amp;newsitemid=20210311005814&amp;lan=en-US&amp;anchor=stock+chart&amp;index=3&amp;md5=ae51a1de218d7ebe9455b69078126d36\">stock chart<\/a>.\n<\/p>\n<p>\n\u201cVery early detection of cancer may ultimately lead to the end of the dreaded disease,\u201d stated a senior cancer physician.\n<\/p>\n<p>\nManhattan Scientifics\u2019 founder, Marvin Maslow and CEO Manny Tsoupanarias pioneered the developments of HDTV, hydrogen fuel cells, Haptics, and other cutting edge space-age technologies.\n<\/p>\n<p>\nMaslow stated, \u201cWe did it before and we\u2019ll do it again and it won\u2019t be difficult.\u201d Manny T. continued, \u201cAs early investors in disruptive technologies, we\u2019ve seen our market cap rise to approach $1.0 billion and fall to $17M we intend to create increased shareholder values going forward.\u201d<strong><span style=\"font-weight:normal\" \/><\/strong><\/p>\n<p><b>About Manhattan Scientifics, Inc.<\/b><\/p>\n<p>\nManhattan Scientifics Inc. (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mhtx.com&amp;esheet=52394777&amp;newsitemid=20210311005814&amp;lan=en-US&amp;anchor=www.mhtx.com&amp;index=4&amp;md5=dc15872cc91f5ce70af43cf683c46287\">www.mhtx.com<\/a>) is focused on technology transfer and commercialization of transformative technologies.\n<\/p>\n<p><b>Forward-looking statement<\/b><\/p>\n<p>\nThis press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company&#8217;s actual results to differ materially from those projected in such forward-looking statements. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210311005814\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210311005814\/en\/<\/a><\/span><\/p>\n<p>\nManhattan Scientifics, Inc.<br \/>\n<br \/>Manny Tsoupanarias, 917-688-4158<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Manny@mhtx.com\">Manny@mhtx.com<br \/>\n<\/a><br \/>Or<br \/>\n<br \/>Marvin Maslow, 917-923-3300<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Marvin@mhtx.com\">Marvin@mhtx.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America New York<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research Finance Hospitals Banking Professional Services Biotechnology Health Science Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems NEW YORK&#8211;(BUSINESS WIRE)&#8211; Manhattan Scientifics Inc. (OTCQB: MHTX) invested $30 million and a 10-year effort to commercialize the Imagion Biosystems (IBX: AX) super early, non- invasive, non-radioactive Cancer diagnostic, now \u201cpartnered\u201d with MD Anderson Cancer Center, Houston. The company is awaiting regulatory approval to initiate human cancer trials. View the stock chart. \u201cVery early detection of cancer may ultimately lead to the end of the dreaded disease,\u201d stated a senior cancer physician. Manhattan Scientifics\u2019 founder, Marvin Maslow and CEO Manny Tsoupanarias pioneered the developments of HDTV, hydrogen fuel cells, Haptics, and other cutting edge space-age technologies. Maslow stated, \u201cWe did it before and we\u2019ll do &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456183","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems NEW YORK&#8211;(BUSINESS WIRE)&#8211; Manhattan Scientifics Inc. (OTCQB: MHTX) invested $30 million and a 10-year effort to commercialize the Imagion Biosystems (IBX: AX) super early, non- invasive, non-radioactive Cancer diagnostic, now \u201cpartnered\u201d with MD Anderson Cancer Center, Houston. The company is awaiting regulatory approval to initiate human cancer trials. View the stock chart. \u201cVery early detection of cancer may ultimately lead to the end of the dreaded disease,\u201d stated a senior cancer physician. Manhattan Scientifics\u2019 founder, Marvin Maslow and CEO Manny Tsoupanarias pioneered the developments of HDTV, hydrogen fuel cells, Haptics, and other cutting edge space-age technologies. Maslow stated, \u201cWe did it before and we\u2019ll do &hellip; Continue reading &quot;Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-11T17:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems\",\"datePublished\":\"2021-03-11T17:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/\"},\"wordCount\":335,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/\",\"name\":\"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-03-11T17:02:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/","og_locale":"en_US","og_type":"article","og_title":"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems - Market Newsdesk","og_description":"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems NEW YORK&#8211;(BUSINESS WIRE)&#8211; Manhattan Scientifics Inc. (OTCQB: MHTX) invested $30 million and a 10-year effort to commercialize the Imagion Biosystems (IBX: AX) super early, non- invasive, non-radioactive Cancer diagnostic, now \u201cpartnered\u201d with MD Anderson Cancer Center, Houston. The company is awaiting regulatory approval to initiate human cancer trials. View the stock chart. \u201cVery early detection of cancer may ultimately lead to the end of the dreaded disease,\u201d stated a senior cancer physician. Manhattan Scientifics\u2019 founder, Marvin Maslow and CEO Manny Tsoupanarias pioneered the developments of HDTV, hydrogen fuel cells, Haptics, and other cutting edge space-age technologies. Maslow stated, \u201cWe did it before and we\u2019ll do &hellip; Continue reading \"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-11T17:02:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems","datePublished":"2021-03-11T17:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/"},"wordCount":335,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/","name":"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-03-11T17:02:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210311005814r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manhattan-scientifics-inc-stock-chart-mimics-that-of-its-largest-investment-to-date-imagion-biosystems\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Manhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456183"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456183\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}